Alana B. McNulty

Insider Reports History

Location
San Diego, CA
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alana B. McNulty:

Company Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Director Common Stock 6,250 $159,750 $25.56 11 Jun 2025 Direct
eFFECTOR Therapeutics, Inc. Chief Business Officer Common Stock 48,768 $29,578 $0.6065 25 Aug 2021 Direct
eFFECTOR Therapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 150,000 20 Jun 2022 Direct
eFFECTOR Therapeutics, Inc. Chief Business Officer Earn-out Right 91,826 25 Aug 2021 Direct
Janux Therapeutics, Inc. Director Stock Option (right to buy) 11,667 11 Jun 2025 Direct

Insider Reports Filed by Alana B. McNulty

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JANX Janux Therapeutics, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 19:30
JANX Janux Therapeutics, Inc. 26 Jun 2024 2 $0 4 Director 28 Jun 2024, 16:30
NKGN NKGen Biotech, Inc. 29 Sep 2023 0 $0 3 Director 10 Oct 2023, 16:13
JANX Janux Therapeutics, Inc. 14 Jun 2023 1 $0 4 Director 16 Jun 2023, 17:09
EFTR eFFECTOR Therapeutics, Inc. 20 Jun 2022 1 $0 4 Chief Business Officer 22 Jun 2022, 16:19
JANX Janux Therapeutics, Inc. 14 Jun 2022 1 $0 4 Director 16 Jun 2022, 16:36
EFTR eFFECTOR Therapeutics, Inc. 20 Jan 2022 1 $0 4 Chief Business Officer 24 Jan 2022, 19:10
JANX Janux Therapeutics, Inc. 07 Sep 2021 1 $0 4 Director 09 Sep 2021, 17:36
JANX Janux Therapeutics, Inc. 07 Sep 2021 0 $0 3 Director 09 Sep 2021, 17:32
EFTR eFFECTOR Therapeutics, Inc. 25 Aug 2021 9 $0 4 Chief Business Officer 27 Aug 2021, 18:11
EFTR eFFECTOR Therapeutics, Inc. 25 Aug 2021 0 $0 3 Chief Business Officer 27 Aug 2021, 18:07